English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17524/19853 (88%)
Visitors : 6426115      Online Users : 720
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32240


    標題: Impact of Hyperbaric Oxygen Therapy on Subsequent Neurological Sequelae Following Carbon Monoxide Poisoning
    作者: Huang, Chien-Cheng
    Ho, Chung-Han
    Chen, Yi-Chen
    Hsu, Chien-Chin
    Wang, Yi-Fong
    Lin, Hung-Jung
    Wang, Jhi-Joung
    Guo, How-Ran
    貢獻者: Chi Mei Med Ctr, Dept Emergency Med
    Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth
    Southern Taiwan Univ Sci & Technol, Dept Senior Serv
    Chi Mei Med Ctr, Dept Med Res
    Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
    Southern Taiwan Univ Sci & Technol, Dept Biotechnol
    Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management
    Taipei Med Univ, Dept Emergency Med
    Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med
    Natl Cheng Kung Univ Hosp, Occupat Safety Hlth & Hlth Res Ctr
    關鍵字: carbon monoxide poisoning
    hyperbaric oxygen therapy
    neurological sequelae
    日期: 2018-10
    上傳時間: 2019-11-15 15:46:27 (UTC+8)
    出版者: MDPI
    摘要: The purpose of this study was to evaluate the effects of hyperbaric oxygen therapy (HBOT) on reducing neurological sequelae (NS) in patients with carbon monoxide poisoning (COP). Using a nationwide database of insurance claims in Taiwan, we conducted a population-based cohort study to identify 24,046 patients with COP diagnosed between 1999 and 2012, including 6793 (28.2%) patients who received HBOT and 17,253 (71.8%) patients who did not. We followed the two cohorts of patients and compared the occurrence of NS. The two cohorts had similar sex ratios, but patients who received HBOT were younger (34.8 +/- 14.8 vs. 36.1 +/- 17.2 years, p < 0.001). Patients who received HBOT had a higher risk for NS (adjusted hazard ratio [AHR]: 1.4; 95% confidence interval [CI]: 1.4-1.5), after adjusting for age, sex, underlying comorbidities (hypertension, diabetes, chronic obstructive pulmonary disease, hyperlipidemia, malignancy, coronary artery disease, congestive heart failure, liver disease, renal disease, connective tissue disease, human immunodeficiency virus [HIV] infection, and alcoholism), monthly income, suicide, drug poisoning, and acute respiratory failure. We observed similar findings when we stratified the patients by age, sex, underlying comorbidities, and monthly income. The increased risk was most prominent in the first 2 weeks (AHR: 2.4; 95% CI: 2.1-2.7) and remained significant up to 6 months later (AHR: 1.6; 95% CI: 1.4-1.7). The risk for NS was higher in patients with COP who received HBOT than in those who did not, even after considering the possible impact of longer observation periods on survivors. Further studies that included the potential confounding factors we did not measure are needed to confirm findings in this study.
    link: http://dx.doi.org/10.3390/jcm7100349
    關聯: Journal of Clinical Medicine, v.7, n.10, 349
    Appears in Collections:[醫務管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    10.3390-jcm7100349.pdf1016KbAdobe PDF31View/Open
    index.html0KbHTML152View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback